Fundraising FoxIndustrifonden — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
AnaCardio is a Swedish clinical-stage biopharmaceutical company developing novel drugs to treat heart failure, with its lead program AC01 in phase 1b/2a clinical development.
BiotechHealthtechMedical DevicesStockholm, SE
Lars H. Lund(Founder)
Co-investors3B Future Health FundNovo HoldingsPureos BioventuresSound Bioventures
NuvoAir provides virtual-first specialty care for patients with complex heart and lung (cardiopulmonary) conditions, offering proactive and continuous remote and in-person care.
Digital HealthHealthtechMedical DevicesBoston, US
Lorenzo Consoli(Founder)inHakan Sjunnesson(Director)Daniel Spasic(Director)Simon Cartmell(Director)Erik Lystedt(Executive Officer)
BoardGary Kurtzman(Director)
Board seatPatrik Sobocki· per SEC Form D
Co-investorsAlbionVCHikma VenturesKAYASpiltan Invest
Cascade Drives develops linear actuators based on cascade gearbox technology for electrification of industrial applications.
Advanced ManufacturingCleantechEnergyHardwareMobility & TransportationSollentuna, SE
Patrik Möller(Co-founder)Stig Lundbäck(Co-founder)Kristian Floresjö(CEO)
Co-investorsEIT InnoEnergyTechFounders
Disruptive Pharma AB (formerly Guard Therapeutics International AB) is a pharmaceutical company listed on Nasdaq First North Growth Market under the ticker DPHA.
BiotechHealthtech
Tobias Agervald(CEO)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.